Goldentree Asset Management LP Purchases New Holdings in Ardent Health Partners, LLC (NYSE:ARDT)

Goldentree Asset Management LP acquired a new stake in shares of Ardent Health Partners, LLC (NYSE:ARDT) in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 1,248,611 shares of the company’s stock, valued at approximately $22,897,000. Ardent Health Partners makes up about 1.8% of Goldentree Asset Management LP’s investment portfolio, making the stock its 19th biggest position. Goldentree Asset Management LP owned 0.87% of Ardent Health Partners at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently bought and sold shares of the business. BNP Paribas Financial Markets acquired a new stake in shares of Ardent Health Partners during the third quarter worth approximately $42,000. Financial Management Professionals Inc. bought a new position in Ardent Health Partners during the 3rd quarter valued at $50,000. MetLife Investment Management LLC acquired a new position in Ardent Health Partners during the 3rd quarter worth $135,000. Charles Schwab Investment Management Inc. bought a new stake in shares of Ardent Health Partners in the 3rd quarter worth about $526,000. Finally, Seven Grand Managers LLC bought a new stake in shares of Ardent Health Partners in the 3rd quarter worth about $2,298,000.

Analyst Upgrades and Downgrades

ARDT has been the subject of several research analyst reports. Leerink Partners boosted their price objective on Ardent Health Partners from $23.00 to $25.00 and gave the company an “outperform” rating in a report on Tuesday, November 12th. Morgan Stanley assumed coverage on Ardent Health Partners in a report on Monday, August 12th. They issued an “overweight” rating and a $27.00 price target for the company. Stephens reissued an “overweight” rating and set a $24.00 price target on shares of Ardent Health Partners in a research report on Thursday, September 19th. JPMorgan Chase & Co. assumed coverage on shares of Ardent Health Partners in a report on Monday, August 12th. They issued a “neutral” rating and a $18.00 price objective for the company. Finally, Mizuho began coverage on shares of Ardent Health Partners in a report on Monday, August 12th. They set an “outperform” rating and a $20.00 target price on the stock. Two equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Buy” and a consensus target price of $21.82.

Ardent Health Partners Stock Performance

Shares of NYSE:ARDT opened at $15.94 on Friday. The company has a 50 day moving average price of $17.89. The company has a current ratio of 1.91, a quick ratio of 1.78 and a debt-to-equity ratio of 0.78. Ardent Health Partners, LLC has a 52 week low of $14.57 and a 52 week high of $20.72.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.